Shares of the small-cap biotech Intercept Pharmaceuticals (NASDAQ: ICPT) sank by a noteworthy 19% during the first six months of 2021, according to data from S&P Global Market Intelligence. The ...
That deal ushered in a strategy change at Sanwire. And from the looks of things, it’s already adding considerable value. In fact, after streamlining its portfolio to focus solely on leveraging the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback